Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Frontera London

- PMLiVE

Insight gaps leave Biopharma vulnerable to patent cliff crisis, warns expert

With unprecedented patent cliffs looming, putting an estimated $200 to $400 billion in annual global sales at risk , senior strategy consultant and Nmblr founder, Janice MacLennan, is issuing a...

Nmblr

- PMLiVE

Novartis to acquire Excellergy in deal worth up to $2bn

Exl-111, a potential treatment included in the deal, is a central factor in many allergic diseases

- PMLiVE

Poolbeg Pharma appoints Adrian Kilcoyne to Scientific Advisory Board

Kilcoyne previously held senior roles at AstraZeneca, Celgene, Sanofi, Roche and Eli Lilly

- PMLiVE

Novo Nordisk’s Awiqli approved by US FDA as once-weekly basal insulin for patients with type 2 diabetes

The insulin is designed as an alternative to daily basal insulin

- PMLiVE

Sandoz partners with Samsung Bioepis to develop up to five biosimilars

The agreement will expand the pipeline and builds on an existing partnership

- PMLiVE

Pharma’s content paradox: why more content is not the answer

By Rasmus Blom

- PMLiVE

Achieving comms excellence through personalised engagement

By Daniel Gibbs

- PMLiVE

Merck agrees on $2.2bn deal with Quotient Therapeutics to develop IBD treatment

Quotient’s somatic genomics platform technology will be used to develop the treatment

Before and after

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

Cuttsy + Cuttsy

- PMLiVE

Ipsen appoints Michelle Werner as Executive Vice President, President of North America

Werner previously held senior roles at Bristol Myers Squibb, AstraZeneca and Novartis

- PMLiVE

The digital age and the advance of AI – pushing communications to new heights

As new comms excellence opportunities abound, staying connected through core messaging remains critical

- PMLiVE

Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development

The Alliance calls for funding and expertise for the next phase of its social media project, marking its first direct engagement with oncology, rare disease and cardiology patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links